Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001744981-19-000001
Filing Date
2019-02-07
Accepted
2019-02-07 18:19:04
Documents
1
Period of Report
2019-02-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 12193
  Complete submission text file 0001744981-19-000001.txt   14545
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Issuer) CIK: 0001595585 (see all company filings)

EIN.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 YALE AVE N SEATTLE WA 98109
Business Address 500 YALE AVE N SEATTLE WA 98109 504-715-8335
Sibling Capital Ventures LLC (Reporting) CIK: 0001744971 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38558 | Film No.: 19576682

Mailing Address 500 YALE AVE N SEATTLE WA 98109
Business Address 500 YALE AVE N SEATTLE WA 98109 504-715-8335
Sibling Co-Investment LLC (Reporting) CIK: 0001744976 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38558 | Film No.: 19576683

Mailing Address 500 YALE AVE N SEATTLE WA 98109
Business Address
Isern Brian M. (Reporting) CIK: 0001744981 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38558 | Film No.: 19576681